Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion.

Wu, Jia-Feng; Chang, Kai-Chi; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei

Wu, Jia-Feng; Chang, Kai-Chi; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei.

Affiliation

Wu JF; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Chang KC; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Ni YH; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Hsu HY; Department of Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chang MH; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.

J Infect Dis ; 223(8): 1381-1389, 2021 04 23.

Article in En | MEDLINE | ID: mdl-32860707

Subject(s)

Antibodies, Viral/blood; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Liver Cirrhosis; Promoter Regions, Genetic; Antiviral Agents/therapeutic use; B7-H1 Antigen; Hepatitis B e Antigens/immunology; Hepatitis B virus/genetics; Hepatitis B, Chronic/drug therapy; Humans; Liver Cirrhosis/drug therapy; Liver Cirrhosis/virology; Mutation; Seroconversion

Key words

antiviral agents; hepatitis B virus; liver stiffness measurement; transient elastography

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Promoter Regions, Genetic / Hepatitis B, Chronic / Hepatitis B e Antigens / Liver Cirrhosis / Antibodies, Viral Limits: Humans Language: En Journal: J Infect Dis Year: 2021 Type: Article Affiliation country: Taiwan

Fulltext

XML

PubMed Links

Search on Google